STOCK TITAN

AORT insider files Form 144 for 7,992-share sale on NYSE

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Artivion filed a Form 144 reporting a proposed sale of 7,992 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $307,612.08. The filing lists total shares outstanding as 47,183,658 and shows the securities were acquired on 08/08/2025 via a stock option exercise with payment made in cash.

The filer reports “Nothing to Report” for sales in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information. The notice is a formal Rule 144 disclosure of a planned insider sale.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Insider exercised options and filed a Form 144 to sell 7,992 shares; filing discloses cash payment and broker details.

The Form 144 documents an insider sale tied to a stock option exercise executed and paid in cash on 08/08/2025. The sale is to be routed through Morgan Stanley Smith Barney LLC on the NYSE and the filing reports aggregate market value of $307,612.08. The filer reports no other sales in the prior three months. From a financial perspective, this is a standard disclosure of an insider liquidity event; the filing provides transparency on timing, quantity, and payment method.

TL;DR: Routine Rule 144 notice reflecting an option exercise and planned sale; includes seller certification about undisclosed material information.

The document is a formal Rule 144 notice showing the insider exercised options and intends to sell the resulting 7,992 shares. The filing includes the required certification that the seller is not aware of material adverse information and references Rule 10b5-1 plan adoption language without providing a plan date. It is a governance-compliant disclosure of an insider transaction; no regulatory exceptions or qualifications are disclosed within the form.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Artivion (AORT) report in this Form 144?

The filing reports a proposed sale of 7,992 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $307,612.08.

When will the sale reported on the AORT Form 144 occur?

The approximate date of sale listed in the filing is 08/08/2025.

How were the shares being sold acquired according to the filing?

The securities were acquired on 08/08/2025 by stock option exercise and payment was made in cash.

Who is the broker handling the proposed sale for AORT?

The filing names Morgan Stanley Smith Barney LLC as the broker.

Did the filer report any other sales of Artivion securities in the past three months?

The filing states “Nothing to Report” for securities sold during the past three months.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.22B
43.29M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW